Posted by tiger86 > 2017-04-17 14:09 | Report Abuse

Mother will fly soon.Good Luck!!

Posted by gnimalu23 > 2017-04-17 14:38 | Report Abuse

anyone got link to the news that bioalpha intends to list on the main market ?

Posted by Yipipang > 2017-04-17 14:43 | Report Abuse

http://www.klsescreener.com/v2/news/view/221819

Posted by Yipipang > 2017-04-17 14:44 | Report Abuse

ACE Market firm Bioalpha Holdings Bhd, which is targeting a Main Board listing, is counting on its exclusive tie-up with national cooperative organisation Angkasa to propel its domestic earnings in the coming years alongside the positive breakthroughs that it has made in overseas markets.

Reflecting its outsized ambitions for a small cap company, Bioalpha has already established a diverse set of businesses in the span of two years since its 2015 listing. Among others, the company co-manages the Constant chain of pharmacies, distributes its own brand of healthcare products, and cultivates its own plants for extraction purposes.

In an interview, Bioalpha’s managing director William Hon Tian Kok highlighted its business partnership with Angkasa as a fruitful and highly rewarding. The Angkasa counts a whopping 12,000 co-operatives as members with a total client base of eight million. The biggest co-operatives under this umbrella include the Royal Malaysia Police co-operative, Koperasi Permodalan Felda (KPF), and Koperasi Petronas (Kopetro).

“Our focus is on Constant. We aim to have 30 outlets by year-end from 15 currently and the greater number of outlets will bring better turnover. The next opening will be in Kota Bharu and Desa Jerteh in Terengganu,” he said.

The company has moved away from the saturated Klang Valley pharmacy chain market and into other states. The concentration of civil servants and enforcement officers in areas outside Klang Valley is among the prime targets for Bioalpha’s businesses thanks to the access provided by Angkasa.

Bioalpha and Angkasa’s 70:30 joint venture company, Alphacare Sdn Bhd, is involved in the management of Constant Pharmacies. The cost of opening the outlets is borne by franchisees while Alphacare charges a fixed management fee from each outlet’s gross income.

“This joint venture gives us access to Angkasa members all over the country. We have already rolled out a loyalty programme to recruit them as our pharmacy members,” he said.

The members are eligible to purchase the products either at a special price or through a financing scheme arranged by some of the co-operatives which is paid for via monthly wage deductions, Hon explained.

This seems to have played a part in spurring the group’s domestic sales. Inclusive of the earnings of its pharmacy operations, Bioalpha’s domestic revenue base grew by 250% to RM21.21mil in its financial year ended Dec 31, 2016 (FY16) from just RM6.26mil a year ago.

Its latest venture is the creation of a franchise business via a virtual pharmacy called e-Constant which will also be managed by Alphacare. It lets customers purchase Bioalpha’s products online and register as referral agents, through which they will be rewarded with cash points for each successful referral sale. The points can then be used for their next purchase of products.

In a recent note, CIMB Research cited the arrangement as a win-win deal for Bioalpha and Angkasa. Co-operative members are able to build individual businesses via referrals, while at the same time Bioalpha gets to boost its pharmaceutical and home brand sales, it said. The research house, which currently has not imputed the potential earnings from e-Constant, has a target price of 37 sen for Bioalpha’s shares.

The company can count on a solid revenue mix to insulate it from potential downturns in the domestic market. Overseas earnings currently contribute about 45% to the group’s revenue base. Hon expects the revenue mix to be closer to 50:50 by year-end.

While the “China angle” is an often-cited catalyst among small cap firms in Bursa Malaysia, Bioalpha has distinguished itself with real and tangible earnings contribution from the world’s most populous nation. In fact, revenue from China now accounts for nearly a third of the company’s revenue base as at FY16.

“Our customers in China re-sell our products the conventional way, that it through outlets and online marketplaces. If you browse through listing on Chinese sites like Tmall and Taobao, you will see a lot of Malaysian healthcare products for sale. It is a big growth market,” he said,

Elsewhere, the group currently sells seven products in Indonesia and hopes to get another six approved by regulators by this year. By having its own factory in Pekan, Riau province, Bioalpha is able to expedite the approval process for its products compared to importing it from Malaysia, Hon said.

It may come as a surprise that the company’s shares have actually underperformed the broader market’s recent advance. Despite its 30% advance year to date, the stock is is down slightly on a year-on-year basis. In comparison, the FBM KLCI Small Cap Index has advanced % to date.

There is also the matter of the group’s high earnings multiple which may put off some investors. It currently carries a price earnings ratio of 20 times according to Bloomberg data, though the figure could also represent investors’ enthusiam over its consistently high profit

Posted by red_85 > 2017-04-17 15:45 | Report Abuse

by looking at anzo today big drop, we will know that penny theme ending soon,...jump ship before this penny crash!

Posted by Yipipang > 2017-04-17 15:54 | Report Abuse

u mean Bioalpha is penny stock??

Posted by IncredibleThings > 2017-04-17 16:08 | Report Abuse

Guys. Make decision by urself based on all the news surround biohldg. No need to care about those who didnt do research before comment. They just trying to spread negative news and also have a sour grape mind. We believe bioalpha is able to go into main market by this year or next year. We should believe in the directors

Posted by IncredibleThings > 2017-04-17 16:11 | Report Abuse

And also, a lot of stock also risen from penny stock. Now you think bioalpha is a penny stock because you didnt see the hidden gem in this company. Once you found the gem. It is too late for you to buy with such cheap price.

Posted by Yipipang > 2017-04-17 16:11 | Report Abuse

just surprise the price totally cant move today. with such comment from director it should be at least have some show...

Posted by IncredibleThings > 2017-04-17 16:12 | Report Abuse

Maybe the show will delay lar but it will come. Buy now and keep it until it reach RM1 or even higher.

Posted by Yipipang > 2017-04-17 16:12 | Report Abuse

mostly will gap up after mention about listed at main board, but I will still decide to hold it for long term

Posted by klsefighter > 2017-04-17 16:21 | Report Abuse

I top up more today at 0.255 ...

Posted by IncredibleThings > 2017-04-17 16:24 | Report Abuse

Lolz still q-ing on 255

Posted by Yun Lih > 2017-04-17 16:48 | Report Abuse

Ya pls dispose this shit of lousy stock :p
Penny theme over!!! Run now pls run now!!!

Please dispose all ur share to me regret no top up enough when it trading below 0.23

Posted by tiger86 > 2017-04-17 16:51 | Report Abuse

Come come who think that this is a lousy stock, now u can throw out ur share, then I buy it. Don regret, if this stock like a train shoot fast to north.

Posted by Ssmani > 2017-04-17 16:59 | Report Abuse

After load more at 0.260, suddenly ppl throw a lot at 0.255 :( but will buy again if price go down, good stock no worries

Posted by ryan7642 > 2017-04-17 19:08 | Report Abuse

Ya me too just done top up:) this stock might not suit for t3 play depend timing..better buy n hold little bit:)

Posted by tiger86 > 2017-04-17 19:13 | Report Abuse

I just top up on 0.26,if drop down again, I will buy more.

Posted by Lim Soon Chai > 2017-04-17 19:18 | Report Abuse

beli anak 0.185

Posted by Yipipang > 2017-04-17 20:47 | Report Abuse

Just know the founder or MD background Hon William, he is qualified accountant. I always believed that the person as a accountant will lead the company become more success, in term of cost control, management and future grow.

Posted by Lim Soon Chai > 2017-04-17 21:24 | Report Abuse

Yipipang, 对于Hon William大量卖出持有的股份，请问你的看法是什么？

Posted by Yipipang > 2017-04-17 21:54 | Report Abuse

不确定。

Posted by hisehatu > 2017-04-17 23:07 | Report Abuse

Back to square. I bought son at 0.185 last 2 weeks. Damn!

Posted by Paul Cheong Wing Chong > 2017-04-18 01:10 | Report Abuse

不是价格不动，而是太多散户丢票！800万票要甩掉散户谈何容易，上一两个价位就丢票，要推上去需要非常长的时间！就算推上去了也被散户丢回下来。

Posted by yeekarwai 95 > 2017-04-18 09:10 | Report Abuse

散户哪里有这样的能力，一卖就卖几百万股?

Posted by Lim Soon Chai > 2017-04-18 09:13 | Report Abuse

时机未到而已，散户一般没有能耐把价位压下来，如果炒家真炒的话。压下来的票应该是炒家自己的，就是搞不懂为何这么做，是因为炒家票还没吃够吗还是等更好的消息出炉？

Posted by iamgreenninja > 2017-04-18 09:16 | Report Abuse

what is happening today? A fierce war is being fought between buyers at 0.25 and sellers at 0.255. No clear winner yet.

Posted by tkp2 > 2017-04-18 09:18 | Report Abuse

Today operator is getting more aggressive to force retailer to sell, don't get into their trap. hold tight tight, show is coming soon

Posted by iamgreenninja > 2017-04-18 09:19 | Report Abuse

The 0.25 defensive wall must not crack!

Posted by Ssmani > 2017-04-18 09:37 | Report Abuse

一般上庄家要推上时，都会丢票让散户也跟着丢。一边丢另一边又收，是时候了就会推很高。之前Dnex的盘也是这样的。基本面好的公司是不怕的hold tight

Posted by Yipipang > 2017-04-18 09:44 | Report Abuse

赞成

Posted by adamdacutie > 2017-04-18 10:14 | Report Abuse

y jus hold? buy man !

Posted by Tortoise > 2017-04-18 10:24 | Report Abuse

http://www.klsescreener.com/v2/news/view/221819

Posted by winmoney996 > 2017-04-18 10:49 | Report Abuse

Come liao

Posted by Paul Cheong Wing Chong > 2017-04-18 10:50 | Report Abuse

买吧，这个动作不简单了，一定有东西的

Posted by Ssmani > 2017-04-18 10:53 | Report Abuse

In a recent note, CIMB Research cited the arrangement as a win-win deal for Bioalpha and Angkasa. Co-operative members are able to build individual businesses via referrals, while at the same time Bioalpha gets to boost its pharmaceutical and home brand sales, it said. The research house, which currently has not imputed the potential earnings from e-Constant, has a target price of 37 sen for Bioalpha’s shares.

Posted by Lim Soon Chai > 2017-04-18 10:58 | Report Abuse

虽然我很相信bio一定会推，但也真的等到很sien。

Posted by imlearning > 2017-04-18 10:59 | Report Abuse

是的，等到很sien

Posted by Lim Soon Chai > 2017-04-18 11:04 | Report Abuse

知道它会来，票又不能丢，

Posted by Ssmani > 2017-04-18 11:06 | Report Abuse

别急别sien，让Bio慢慢的成长转去main board…… 大家别忘了多2个季度就会看到eC的收入了：）

Posted by Lim Soon Chai > 2017-04-18 11:07 | Report Abuse

tq

Posted by Lim Soon Chai > 2017-04-18 11:10 | Report Abuse

2季就是要到年底去了，要跨过8月和11月的出业绩月份，难搞。

Posted by winmoney996 > 2017-04-18 11:19 | Report Abuse

Biohldg, 稳稳

Posted by Ssmani > 2017-04-18 11:22 | Report Abuse

我看了这盘有2个月了，昨天才进的因为对Bio的信心越来越强了……你们买在低价更爽啦

Posted by winmoney996 > 2017-04-18 14:38 | Report Abuse

我在Bonus issue 前收到现在，看到麻木了

Posted by Lim Soon Chai > 2017-04-18 14:41 | Report Abuse

请问给bonus前是什么价位啊？多少粒给一粒？

Posted by winmoney996 > 2017-04-18 14:47 | Report Abuse

0.370~0.375 3送1

Posted by winmoney996 > 2017-04-18 14:48 | Report Abuse

如果在这个价位买 Issue后价位在0.245

Posted by happycool > 2017-04-18 14:51 | Report Abuse

https://klse.i3investor.com/servlets/stk/annent/0179.jsp
6 DEC2016

Posted by winmoney996 > 2017-04-18 14:51 | Report Abuse

所以这只股才刚刚Warm up罢了，如果夏季业绩好，eps去到80sen, 股价保守估计估计可以去到40sen以上，一目前的业绩，和理价为0.38